LEO Pharma Open Innovation

Structural confidentiality


Protecting your compounds

LEO Pharma’s Open Innovation invites you to submit compounds for testing in disease-relevant in vitro assays. We are looking for new potential collaborations to develop new drugs for future treatments, while respecting your integrity, trust and need for confidentiality.

To ensure confidentiality we do not ask for structure of confidential compounds – that information will remain with you until we mutually agree otherwise.